Skip to search formSkip to main contentSkip to account menu

Diquafosol Tetrasodium

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PURPOSE The aim of this study was to evaluate the effectiveness of combined tear film therapy targeted to aqueous, mucin, and… 
2016
2016
Purpose: The aim of this study was to evaluate the clinical effect of 3% diquafosol in dry eye patients aged around 60 years… 
2016
2016
The present invention addresses the problem of finding an agent for treating the onset and/or worsening of dry eye symptoms… 
2015
2015
Purpose: To evaluate the clinical efficacy of topical diquafosol tetrasodium 3% ophthalmic solution in patients with short tear… 
2015
2015
(unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non… 
2015
2015
Purpose: To evaluate the clinical effectiveness of topical diquafosol tetrasodium (DQS) after laser epithelial keratomileusis… 
2015
2015
Purpose: To report a case of severe dry eye associated with high myopia by combination therapy with diquafosol tetrasodium and… 
2005
2005
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Review
2003
Review
2003
Inspire, in collaboration with Allergan and Santen, is developing an eye-drop formulation of diquafosol tetrasodium (INS-365), a… 
Review
2003
Review
2003
Diquafosol [INS 365, KPY 998, diquafosol tetrasodium, DE 089, INS 365 Respiratory, INS 365 Ophthalmic] is a mucolytic compound…